Neomycin + Bacitracin Ointment Suppliers & Bulk Manufacturers
Available Forms: Ointment
Available Strengths: neomycin 3.5 mg, bacitracin 400 units, and polymyxin B 10,000 units
Reference Brands: Neosporin(US & EU)
Category:
Derma Drugs
Neomycin + Bacitracin ointment combines two antibiotics that inhibit bacterial protein and cell wall synthesis, respectively. It effectively treats minor skin wounds, cuts, and infections, promoting faster healing, preventing bacterial spread, and reducing infection risk. Suitable for topical use to support skin barrier protection.
Neomycin + Bacitracin Ointment is available in Ointment
and strengths such as neomycin 3.5 mg, bacitracin 400 units, and polymyxin B 10,000 units.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Neomycin + Bacitracin Ointment is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Neomycin + Bacitracin Ointment can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Neomycin and Bacitracin ointment is approved in both the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing compliance with GMP standards. In the US, FDA regulations oversee safety and quality, while in the EU, CE marking certifies conformity with in vitro diagnostic standards. These products undergo validation, stability testing, and quality audits, with comprehensive documentation including safety profiles, clinical data, and production details. Proper licensing, dossier submission, and regulatory updates are essential for market access. For detailed licensing procedures, approved dossiers, and the latest regulatory information, visit Pharmatradz. Ensuring compliance guarantees availability of safe, effective topical antibiotics globally.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing